These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26886298)

  • 21. Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond.
    Murakami T; Fujimoto H; Inagaki N
    Front Endocrinol (Lausanne); 2021; 12():714348. PubMed ID: 34248856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
    Selvaraju RK; Velikyan I; Asplund V; Johansson L; Wu Z; Todorov I; Shively J; Kandeel F; Eriksson B; Korsgren O; Eriksson O
    Nucl Med Biol; 2014 Jul; 41(6):471-6. PubMed ID: 24857864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of
    Brom M; Joosten L; Frielink C; Peeters H; Bos D; van Zanten M; Boerman O; Gotthardt M
    Diabetes; 2018 Oct; 67(10):2012-2018. PubMed ID: 30045920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET/MRI enables simultaneous
    Michelotti FC; Bowden G; Küppers A; Joosten L; Maczewsky J; Nischwitz V; Drews G; Maurer A; Gotthardt M; Schmid AM; Pichler BJ
    Theranostics; 2020; 10(1):398-410. PubMed ID: 31903128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
    Zhang B; Yang B; Zhai C; Jiang B; Wu Y
    Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of
    Kimura H; Matsuda H; Ogawa Y; Fujimoto H; Toyoda K; Fujita N; Arimitsu K; Hamamatsu K; Yagi Y; Ono M; Inagaki N; Saji H
    Bioorg Med Chem; 2017 Feb; 25(4):1406-1412. PubMed ID: 28089587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT.
    Murakami T; Fujimoto H; Fujita N; Hamamatsu K; Matsumoto K; Inagaki N
    Endocrinology; 2019 Dec; 160(12):2959-2968. PubMed ID: 31613319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.
    Wild D; Wicki A; Mansi R; Béhé M; Keil B; Bernhardt P; Christofori G; Ell PJ; Mäcke HR
    J Nucl Med; 2010 Jul; 51(7):1059-67. PubMed ID: 20595511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets.
    Wu Z; Liu S; Hassink M; Nair I; Park R; Li L; Todorov I; Fox JM; Li Z; Shively JE; Conti PS; Kandeel F
    J Nucl Med; 2013 Feb; 54(2):244-51. PubMed ID: 23297075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.
    Lehtonen J; Schäffer L; Rasch MG; Hecksher-Sørensen J; Ahnfelt-Rønne J
    Islets; 2015; 7(6):e1137415. PubMed ID: 26963143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT.
    van der Kroon I; Andralojc K; Willekens SM; Bos D; Joosten L; Boerman OC; Brom M; Gotthardt M
    J Nucl Med; 2016 May; 57(5):799-804. PubMed ID: 26795287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.
    Xu Q; Zhu C; Xu Y; Pan D; Liu P; Yang R; Wang L; Chen F; Sun X; Luo S; Yang M
    J Drug Target; 2015; 23(9):813-20. PubMed ID: 25758750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
    Wu Z; Todorov I; Li L; Bading JR; Li Z; Nair I; Ishiyama K; Colcher D; Conti PE; Fraser SE; Shively JE; Kandeel F
    Bioconjug Chem; 2011 Aug; 22(8):1587-94. PubMed ID: 21692471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4.
    Eriksson O; Korsgren O; Selvaraju RK; Mollaret M; de Boysson Y; Chimienti F; Altai M
    Acta Diabetol; 2018 Jan; 55(1):49-57. PubMed ID: 29064047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity.
    Seo D; Faintuch BL; Aparecida de Oliveira E; Faintuch J
    Nucl Med Biol; 2017 Jun; 49():57-64. PubMed ID: 28365524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET.
    Bauman A; Valverde IE; Fischer CA; Vomstein S; Mindt TL
    J Nucl Med; 2015 Oct; 56(10):1569-74. PubMed ID: 26251418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin.
    van der Kroon I; Woliner-van der Weg W; Brom M; Joosten L; Frielink C; Konijnenberg MW; Visser EP; Gotthardt M
    Sci Rep; 2017 Jan; 7():39800. PubMed ID: 28067253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of β-cell-dependent contrast enhancement in the pancreas.
    Clough TJ; Baxan N; Coakley EJ; Rivas C; Zhao L; Leclerc I; Martinez-Sanchez A; Rutter GA; Long NJ
    Dalton Trans; 2020 Apr; 49(15):4732-4740. PubMed ID: 32207493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of radiolabelled exendin for beta cell imaging by ex vivo autoradiography and immunohistochemistry of human pancreas.
    Jansen TJP; Tokgöz S; Buitinga M; van Lith SAM; Joosten L; Frielink C; Smeets EMM; Stommel MWJ; van der Kolk MB; de Galan BE; Brom M; Boss M; Gotthardt M
    EJNMMI Res; 2024 Oct; 14(1):96. PubMed ID: 39405026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of GLP-1 and gastrin signalling induces in vivo reprogramming of pancreatic exocrine cells into beta cells in mice.
    Sasaki S; Miyatsuka T; Matsuoka TA; Takahara M; Yamamoto Y; Yasuda T; Kaneto H; Fujitani Y; German MS; Akiyama H; Watada H; Shimomura I
    Diabetologia; 2015 Nov; 58(11):2582-91. PubMed ID: 26290048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.